MedPath
TGA Approval

STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle (194081)

194081

STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle

Gilead Sciences Pty Ltd

February 22, 2013

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/4d9237dd5f6a1a3f9357078e964e1609.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/c80f0cf9a7c7ee07a2df2e302a7121ac.pdf

Active Ingredients

cobicistat

elvitegravir

emtricitabine

tenofovir disoproxil fumarate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle (194081) - TGA 批准文号 | MedPath